Profil
William Earnest Pullman is currently a Director at Proximagen Group Plc and a Director at USL Pharma International UK Ltd. He previously worked as the Chief Medical Officer & Senior Vice President at Cubist Pharmaceuticals LLC, the Chief Development Officer & Executive VP at Dyax Corp., and the Senior Vice President-Exploratory Development at TransForm Pharmaceuticals, Inc. Pullman holds a doctorate degree from both the Australian National University and The University of Western Australia.
Aktiva positioner av William Earnest Pullman
| Företag | Position | Start |
|---|---|---|
USL Pharma International UK Ltd.
USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology Operates as holding company whose subsidiaries develops drugs for the treatment of neurological and inflammatory disorders | Direktör/Styrelseledamot | 2013-12-18 |
Proximagen Group Ltd.
Proximagen Group Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics designed for the treatment of central nervous system diseases | Direktör/Styrelseledamot | 2013-12-18 |
Tidigare kända positioner av William Earnest Pullman
| Företag | Position | Slut |
|---|---|---|
| DYAX CORP. | Teknisk/Vetenskaplig/F&U Direktör | - |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Företagsledare/Principal | - |
| CUBIST PHARMACEUTICALS INC | Teknisk/Vetenskaplig/F&U Direktör | - |
William Earnest Pullmans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Dyax Corp.
Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Proximagen Group Ltd.
Proximagen Group Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics designed for the treatment of central nervous system diseases | Health Technology |
Australian National University
Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
USL Pharma International UK Ltd.
USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology Operates as holding company whose subsidiaries develops drugs for the treatment of neurological and inflammatory disorders | Health Technology |
















